130 related articles for article (PubMed ID: 35289354)
21. Use of Botulinum Toxin and Hyaluronic Acid Filler to Treat Oral Involvement in Scleroderma.
Cumsky HJL; Pham MM; Hoss E
Dermatol Surg; 2022 Jun; 48(6):698-699. PubMed ID: 35333209
[No Abstract] [Full Text] [Related]
22. Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro- a pilot study.
Jäger C; Brenner C; Habicht J; Wallich R
Exp Dermatol; 2012 Jan; 21(1):72-5. PubMed ID: 22151394
[TBL] [Abstract][Full Text] [Related]
23. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
24. Aesthetic botulinum A toxin in the mid and lower face and neck.
Carruthers J; Carruthers A
Dermatol Surg; 2003 May; 29(5):468-76. PubMed ID: 12752513
[TBL] [Abstract][Full Text] [Related]
25. Update on botulinum toxin.
Flynn TC
Semin Cutan Med Surg; 2007 Dec; 26(4):196-202. PubMed ID: 18395667
[TBL] [Abstract][Full Text] [Related]
26. Employing hyaluronic acid-based mesotherapy for facial rejuvenation.
Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
J Cosmet Dermatol; 2022 Dec; 21(12):6605-6618. PubMed ID: 36098653
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study.
Wu Y; Zhao G; Li H; Zheng Z; Zhong S; Yang Z; Feng Z; Yang Q; Zhu X
Dermatol Surg; 2010; 36(1):102-8. PubMed ID: 20002637
[TBL] [Abstract][Full Text] [Related]
28. Invited Discussion on "Comparison of Effectiveness and Safety of a Botulinum Toxin Mono Therapy and a Combination Therapy with Hyaluronic Acid Filler for Improving Glabellar Frown".
Hodgkinson DJ; Kappen IFPM
Aesthetic Plast Surg; 2022 Aug; 46(4):1881-1883. PubMed ID: 35608681
[No Abstract] [Full Text] [Related]
29. Recent modalities in treatment of telogen effluvium: Comparative study.
Khattab FM; Rady A; Khashaba SA
Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
[TBL] [Abstract][Full Text] [Related]
30. [Tratamientos estéticos. Posición de la Academia Nacional de Medicina de México].
Mansilla-Olivares A; Santos-Preciado JI; Plancarte-Sánchez R; Meneses-González F; Valenzuela-Gómez-Gallardo F; López-Bárcena J; Anda GFV
Gac Med Mex; 2018; 154(6):740-741. PubMed ID: 30532103
[TBL] [Abstract][Full Text] [Related]
31. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone.
Custis T; Beynet D; Carranza D; Greco J; Lask GP; Kim J
Dermatol Surg; 2010 Nov; 36 Suppl 3():1852-8. PubMed ID: 20969662
[TBL] [Abstract][Full Text] [Related]
32. A randomized study showing improved skin quality and aesthetic appearance of dorsal hands after hyaluronic acid gel treatment in a Chinese population.
Wu Y; Tian Y; Xu J; Zhong S; Wang R; Wu W
J Cosmet Dermatol; 2020 Jul; 19(7):1627-1635. PubMed ID: 31769596
[TBL] [Abstract][Full Text] [Related]
33. Combination Facial Aesthetic Treatment in Millennials.
Kurtti A; Charles C; Jagdeo J; Nguyen J
J Drugs Dermatol; 2022 Jan; 21(1):37-42. PubMed ID: 35005865
[TBL] [Abstract][Full Text] [Related]
34. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A.
Carruthers J; Carruthers A
Dermatol Surg; 2003 Aug; 29(8):802-9. PubMed ID: 12859378
[TBL] [Abstract][Full Text] [Related]
35. Mesotherapy with an Intradermal Hyaluronic Acid Formulation for Skin Rejuvenation: An Intrapatient, Placebo-Controlled, Long-Term Trial Using High-Frequency Ultrasound.
Tedeschi A; Lacarrubba F; Micali G
Aesthetic Plast Surg; 2015 Feb; 39(1):129-33. PubMed ID: 25539986
[TBL] [Abstract][Full Text] [Related]
36. Mesotherapy.
Galadari H; Al Faresi F
Skinmed; 2011; 9(6):342-3. PubMed ID: 22256620
[No Abstract] [Full Text] [Related]
37. Cosmetic use of botulinum A exotoxin for the aging neck.
Brandt FS; Bellman B
Dermatol Surg; 1998 Nov; 24(11):1232-4. PubMed ID: 9834744
[TBL] [Abstract][Full Text] [Related]
38. Two different types of botulinum toxins: Is there a difference in efficacy and longevity?
Shome D; Kapoor R; Khare S
J Cosmet Dermatol; 2019 Dec; 18(6):1635-1641. PubMed ID: 31135088
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of hyaluronic acid filler on the treatment of horizontal neck lines.
Rongthong A; Wanitphakdeedecha R; Maiprasert M; Cembrano KAG; Voravutinon N; Rakchart S; Sermswan K; Koonngam P
J Cosmet Dermatol; 2023 Feb; 22(2):433-438. PubMed ID: 36575878
[TBL] [Abstract][Full Text] [Related]
40. Adjunctive botulinum toxin type A: fillers and light-based therapies.
Carruthers J; Carruthers A
Int Ophthalmol Clin; 2005; 45(3):143-51. PubMed ID: 15970773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
